Absci announces partnership to accelerate drug discovery

Absci Corp. (Nasdaq: ABSI) announced Wednesday it has formed a partnership with Cambridge, Massachusetts-based EQRx to discover and develop new protein-based drugs. Absci, based in Vancouver, specializes in drug and disease target discovery, combining synthetic biology and AI. EQRx is a pharmaceutical company that launched in January 2020 to focus on developing and delivering new medicines at “radically lower prices.” The two companies said they will joi ntly engineer and develop clinical candidates…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news